Resolvin E1
CAT:
HY-114041
HY-114041
804-HY-114041-01
Size:
10 μg (285.3 μM x 100 μL in Ethanol)
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Resolvin E1
Description:
Resolvin E1 (RvE1), a potent endogenous pro-resolving mediator of inflammation, is derived from omega-3 fatty acid eicosapentaenoic acid (EPA) . Resolvin E1 is endogenously biosynthesized from EPA in the presence of Aspirin during the spontaneous resolution phase of acute inflammation, where specific cell-cell interactions occur. Resolvin E1 possesses unique counterregulatory actions that inhibit polymorphonuclear leukocyte (PMN) transendothelial migration. Resolvin E1 also acts as a potent inhibitor of leukocyte infiltration, dendritic cell migration, and IL-12 production[1][2].Product Name Alternative:
RvE1UNSPSC:
12352211Hazard Statement:
H302, H315, H319, H335Target:
Endogenous MetaboliteType:
Natural ProductsRelated Pathways:
Metabolic Enzyme/ProteaseApplications:
COVID-19-immunoregulationField of Research:
Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/resolvin-e1.htmlConcentration:
285.3 μM * 250 μL in EthanolPurity:
98.1Solubility:
Ethanol : 50 mg/mL (ultrasonic; warming)Smiles:
CC[C@@H](O)/C=C/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(O)=OMolecular Formula:
C20H30O5Molecular Weight:
350.45Precautions:
H302, H315, H319, H335References & Citations:
[1]Arita M, et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A. 2005 May 24;102 (21) :7671-6.|[2]Schwab JM, et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007 Jun 14;447 (7146) :869-74.|[3]Hasturk H, et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissuehomeostasis in vivo. J Immunol. 2007 Nov 15;179 (10) :7021-9.Shipping Conditions:
Blue IceStorage Conditions:
Solution, -20°C, 2 yearsScientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
Human Endogenous MetaboliteCAS Number:
[552830-51-0]
